Hepatitis C virus testing of persons born during 1945-1965: recommendations from the Centers for Disease Control and Prevention (Q45355364)

13 December 2017

title

Hepatitis C virus testing of persons born during 1945-1965: recommendations from the Centers for Disease Control and Prevention (English)

1 reference

13 December 2017

1 reference

1 reference

Bryce D Smith

1

1 reference

13 December 2017

Rebecca L Morgan

2

1 reference

13 December 2017

Geoff A Beckett

3

1 reference

13 December 2017

Yngve Falck-Ytter

4

1 reference

13 December 2017

Deborah Holtzman

5

1 reference

13 December 2017

John W Ward

6

1 reference

13 December 2017

language of work or name

English

0 references

publication date

1 December 2012

1 reference

Annals of Internal Medicine

13 December 2017

published in

1 reference

13 December 2017

volume

157

1 reference

13 December 2017

issue

11

1 reference

13 December 2017

page(s)

817-822

1 reference

Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.

13 December 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5777166

Hepatitis B and C virus infection among 1.2 million persons with access to care: factors associated with testing and infection prevalence

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5777166

Annual Report to the Nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5777166

The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007.

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5777166

The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5777166

HCV screening practices and prevalence in an MCO, 2000-2007.

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5777166

Telaprevir for previously untreated chronic hepatitis C virus infection

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5777166

Boceprevir for untreated chronic HCV genotype 1 infection

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5777166

A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C.

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5777166

Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5777166

Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States☆☆☆

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5777166

Clinical approach to the patient with chronic hepatitis C infection and normal aminotransferases.

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5777166

Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5777166

Hepatitis C testing practices and prevalence in a high-risk urban ambulatory care setting.

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5777166

The Institute of Medicine report on viral hepatitis: a call to action

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5777166

Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5777166

Public health impact of antiviral therapy for hepatitis C in the United States

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5777166

HIV risk behavior self-report reliability at different recall periods

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5777166

Telaprevir and peginterferon with or without ribavirin for chronic HCV infection

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5777166

Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5777166

Family physicians' knowledge and screening of chronic hepatitis and liver cancer.

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5777166

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5777166

Effectiveness of brief alcohol interventions in primary care populations

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5777166

Self-reported hepatitis C virus antibody status and risk behavior in young injectors

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5777166

The prevalence of hepatitis C virus infection in the United States, 1999 through 2002

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5777166

Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5777166

Screening for hepatitis C virus infection in adults: recommendation statement

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5777166

Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5777166

Knowledge of hepatitis C screening and management by internal medicine residents: trends over 2 years

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5777166

Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5777166

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5777166

Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5777166

1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. U.S. Public Health Service (USPHS) and Infectious Diseases Society of America (IDSA)

27 August 2018

1 reference

12 December 2020

1 reference

12 December 2020

Current practice patterns of primary care physicians in the management of patients with hepatitis C

1 reference

12 December 2020

Epidemiology of hepatocellular carcinoma in USA

1 reference

12 December 2020

Liver and intestine transplantation in the United States, 1997-2006

1 reference

12 December 2020

10.7326/0003-4819-157-9-201211060-00529

Identifiers

DOI

1 reference

13 December 2017

0 references

1 reference